Back to Search
Start Over
Novartis drug Afinitor[R] significantly extended time without disease progression in women with HER2 positive advanced breast cancer
- Source :
- Thomson Reuters ONE. May 17, 2013
- Publication Year :
- 2013
-
Abstract
- (Thomson Reuters ONE via COMTEX) -- Novartis International AG / Novartis drug Afinitor® significantly extended time without disease progression in women with HER2 positive advanced breast cancer . Processed and [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Thomson Reuters ONE
- Publication Type :
- News
- Accession number :
- edsgcl.330128249